Frontiers in Oncology | Cancer Immunity and Immunotherapy

Review

Published on 01 May 2023

Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials

in Cancer Immunity and Immunotherapy

Minhan Jiang
Steven Fiering
Qi Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1153066

4,189 views
9 citations

Mini Review

Published on 28 Apr 2023

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Lingli Luo
Yuxin Liu
Jingfen Lu
Yifei Zhang
Gang Fan
Xiaojun Tang
Weiming Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1104888

3,086 views
3 citations

Case Report

Published on 28 Apr 2023

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

in Cancer Immunity and Immunotherapy

Jiabao Yang
Pengfei Xing
Yuehong Kong
Meiling Xu
Liyuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1078915

3,967 views
8 citations

Review

Published on 28 Apr 2023

Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives

in Cancer Immunity and Immunotherapy

Shuang Zhang
Ying Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1142081

13,286 views
24 citations

Review

Published on 27 Apr 2023

IDO1 and inflammatory neovascularization: bringing new blood to tumor-promoting inflammation

in Cancer Immunity and Immunotherapy

Alexander J. Muller
Arpita Mondal
Souvik Dey
George C. Prendergast

Frontiers in Oncology

doi 10.3389/fonc.2023.1165298

3,887 views
17 citations

Original Research

Published on 26 Apr 2023

Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Xueyan Liang
Xiaoyu Chen
Huijuan Li
Yan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1113374

2,295 views
1 citation

Original Research

Published on 25 Apr 2023

A new prognostic nomogram in patients with mucosa-associated lymphoid tissue lymphoma: a multicenter retrospective study

in Cancer Immunity and Immunotherapy

Qiuyue Wen
Xiaoqian Li
Kewei Zhao
Qiuhui Li
Fang Zhu
Gang Wu
Tongyu Lin
Liling Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1123469

2,047 views
4 citations

Review

Published on 24 Apr 2023

Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity

in Cancer Immunity and Immunotherapy

Ting Wang
Wangrui Peng
Meng Du
Zhiyi Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1167105

4,428 views
26 citations

Original Research

Published on 21 Apr 2023

The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma

in Cancer Immunity and Immunotherapy

Xiaoyong Xiang
Peng Chen
Fengming Lan
Li Ma
Jing Jin
Ye Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1110281

2,106 views
5 citations

Original Research

Published on 20 Apr 2023

High VISTA expression is linked to a potent epithelial-mesenchymal transition and is positively correlated with PD1 in breast cancer

in Cancer Immunity and Immunotherapy

Ibtissam Rezouki
Basma Zohair
Saadia Ait Ssi
Mehdi Karkouri
Ibtissam Razzouki
Mohamed Elkarroumi
Abdallah Badou

Frontiers in Oncology

doi 10.3389/fonc.2023.1154631

2,952 views
11 citations

Original Research

Published on 20 Apr 2023

Concurrent sintilimab with sequential chemoradiotherapy for unresectable, stage III non-small cell lung cancer: a retrospective study

in Cancer Immunity and Immunotherapy

Shi Tang
Xiaofeng Cong
Dan Zheng
Chen Chen
Zengguang Liu
Jie Gao
Huimin Zhang
Youhao Zhang
Ziling Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1129989

2,357 views
4 citations

Original Research

Published on 19 Apr 2023

Prognostic value of SLC4A4 and its correlation with the microsatellite instability in colorectal cancer

in Cancer Immunity and Immunotherapy

Shaorui Rui
Dong Wang
Yong Huang
Jingyun Xu
Hailang Zhou
Hesong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1179120

2,940 views
7 citations

Review

Published on 19 Apr 2023

UXT at the crossroads of cell death, immunity and neurodegenerative diseases

in Cancer Immunity and Immunotherapy

Pengzhe Han
Shaojian Mo
Zhengwang Wang
Jiale Xu
Xifeng Fu
Yanzhang Tian

Frontiers in Oncology

doi 10.3389/fonc.2023.1179947

3,942 views
5 citations

Systematic Review

Published on 19 Apr 2023

Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy in patients with extensive-stage small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials

in Cancer Immunity and Immunotherapy

Chunlan Chen
Peng Tian
Jiangshan Zhong
Xianming Fan

Frontiers in Oncology

doi 10.3389/fonc.2023.1151769

3,961 views
6 citations

Editorial

Published on 18 Apr 2023

Editorial: Targeting tumor vasculature to enhance cancer immunotherapy

in Cancer Immunity and Immunotherapy

Jieying Yang
Li Fu
Toshiro Shirakawa
Tong Xiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1199811

1,247 views

Case Report

Published on 18 Apr 2023

The surge of HBsAb level in a HBsAg-negative ES-SCLC patient after anlotinib plus atezolizumab treatment: A case report

in Cancer Immunity and Immunotherapy

Gangjun Chen
Tian Tian
Xingdong Cai

Frontiers in Oncology

doi 10.3389/fonc.2023.1103512

2,252 views
1 citation